Qlt Inc (QLTI): Broadfin’s Kevin Kotler to Become Director of Novelion

Page 8 of 8

Page 8 of 8 – SEC Filing
Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13D Amendment, dated September 12, 2016, relating to the Common Stock QLT Inc. shall be filed on behalf of the undersigned.
September 12, 2016
———————–
(Date)
BROADFIN CAPITAL, LLC
By:  /s/ Kevin Kotler
       Kevin Kotler, Managing Member
KEVIN KOTLER
 /s/ Kevin Kotler
BROADFIND HEALTHCARE MASTER FUND, LTD.
By:  /s/ Kevin Kotler
       Kevin Kotler, Director

Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)

Page 8 of 8